Evidence map›Paper›PMID 41145311›Full record

ArticleYonsei medical journal2025

Immediate Postoperative AbnobaVISCUM

Seung Soo Hong, Munseok Choi, Seoung Yoon Rho, Sung Hyun Kim, Ho Kyoung Hwang, Chang Moo Kang

Abstract read
In one paragraph

Article in Yonsei medical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Seung Soo HongDivision of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0001-9913-8437
Munseok ChoiDivision of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-9844-4747
Seoung Yoon RhoDivision of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-1265-826X
Sung Hyun KimDivision of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0001-7683-9687
Ho Kyoung HwangDivision of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0003-4064-7776
Chang Moo KangDivision of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-5382-4658

Funding

LB ABNOBA Co., Ltd. 4-2021-0077
6 · The paper itself

Abstract

purposeAbnobaVISCUM MATERIALS AND

methodsWe reviewed a total of 985 patients who underwent radical resection for pancreatic cancer between January 2005 and August 2022 at Severance Hospital, Seoul, Korea. Patients were divided into two groups based on whether Abnoba VISCUM

resultsOf the 985 patients, 310 received Viscum therapy at least 12 times (Viscum group), while 590 did not receive it at all (Control group). After PSM, both groups showed similar DFS (

conclusionViscum treatment significantly improved OS in patients with completely resected stage I and II pancreatic cancer, particularly among those unable to tolerate adjuvant chemotherapy. This anticancer effect, based on immune enhancement, should be further investigated, and large-scale randomized controlled study is warranted.

Indexed as

Pancreatic NeoplasmsPlant ExtractsAdultAgedChemotherapy, AdjuvantDisease-Free SurvivalFemaleHumansMaleMiddle AgedRetrospective StudiesViscum albumPlant Extractsadjuvant treatmentpancreatic cancerViscum album

Identifiers

PMID41145311
PMCPMC12568445

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.